Financial Counselors Inc Biogen Inc. Transaction History

Financial Counselors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $164,805 - $211,798	-736 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$259.0 - $414.71 $12,432 - $19,906	-48 Reduced 6.12%	736 $255,000
Q1 2021 Apr 29, 2021	SELL	$242.95 - $284.63 $69,240 - $81,119	-285 Reduced 26.66%	784 $219,000
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $945 - $1,422	4 Added 0.38%	1,069 $262,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $2,647 - $3,057	-10 Reduced 0.93%	1,065 $302,000
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $18,623 - $24,663	72 Added 7.18%	1,075 $288,000
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $2,419 - $3,069	9 Added 0.91%	1,003 $317,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $218,739 - $302,245	994 New	994 $295,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.